Compare MDT & SBUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDT | SBUX |
|---|---|---|
| Founded | 1949 | 1971 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.9B | 105.7B |
| IPO Year | N/A | 1992 |
| Metric | MDT | SBUX |
|---|---|---|
| Price | $99.49 | $93.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 24 |
| Target Price | ★ $110.29 | $100.83 |
| AVG Volume (30 Days) | 9.1M | ★ 11.6M |
| Earning Date | 02-17-2026 | 01-28-2026 |
| Dividend Yield | ★ 2.85% | 2.64% |
| EPS Growth | ★ 12.98 | N/A |
| EPS | ★ 3.69 | 1.20 |
| Revenue | $34,758,000,000.00 | ★ $37,701,700,000.00 |
| Revenue This Year | $8.58 | $5.21 |
| Revenue Next Year | $5.88 | $5.50 |
| P/E Ratio | ★ $26.96 | $78.13 |
| Revenue Growth | ★ 5.34 | 4.30 |
| 52 Week Low | $79.55 | $75.50 |
| 52 Week High | $106.33 | $117.46 |
| Indicator | MDT | SBUX |
|---|---|---|
| Relative Strength Index (RSI) | 57.56 | 53.56 |
| Support Level | $98.62 | $90.62 |
| Resistance Level | $105.50 | $101.20 |
| Average True Range (ATR) | 2.12 | 3.17 |
| MACD | -0.12 | -0.17 |
| Stochastic Oscillator | 52.69 | 34.61 |
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
Starbucks stands out as the world's biggest and most recognizable coffee brand, powered by ultracustomizable beverages in-store and a sweeping footprint of nearly 41,000 cafes in over 80 countries. About 52% are company-operated, with the balance run by licensees. The company operates roasteries and sells across its North America (74% of revenue as of the end of fiscal 2025), international (21%), and channel development (5%) segments. The brand collects revenue from company-operated stores, licensee royalties, equipment and product sales, retail ready-to-drink beverages, and packaged coffee.